Literature DB >> 26940375

Exocytosis and Spreading of Normal and Aberrant α-Synuclein.

Evangelia Emmanouilidou1, Kostas Vekrellis1.   

Abstract

It is now established that α-synuclein can be physiologically secreted to the extracellular space. In this sense, mechanisms that govern the secretion of the protein may be of importance in the initiation and progress of synucleinopathies. It is possible that increased secretion may aid the formation of toxic seeds extracellularly. Alternatively, reduced presence of extracellular α-synuclein due to impaired secretion may increase the intracellular load and trigger intracellular seeding. Once outside, α-synuclein can exert various paracrine actions on neighboring cells again by mechanisms that have not been fully elucidated. It has been demonstrated that, when applied extracellularly, α-synuclein species can induce multiple neurotoxic and inflammatory responses, and aid the transmission of pathology between neurons. Still, the exact mechanism(s) by which secreted α-synuclein affects the homeostasis of other neurons is still not well understood. A portion of α-synuclein has been shown to be associated with the surface and lumen of exosomes which can transfer it to the surrounding cells, and potentially trigger seeding. Interestingly, increased exosome release has been linked to pathological situations of lysosomal dysfunction as observed in Parkinson's disease (PD). However, the possibility that the observed α-synuclein pathology spread is attributable to the passive diffusion of the initial injected α-synuclein strains cannot be excluded. Importantly, most of the studies that have so far addressed the role of extracellular α-synuclein have not employed naturally secreted forms of the protein. It is plausible that deregulation in the normal processing of secreted α-synuclein may aid the formation of "toxic" species and as such it may also be a causative risk factor for PD. In this capacity, elucidation of the underlying mechanisms that regulate the protein-levels of extracellular α-synuclein becomes essential. Such mechanisms could involve its proteolytic clearance from the extracellular milieu.
© 2016 International Society of Neuropathology.

Entities:  

Keywords:  aggregates; exocytosis; exosomes; propagation; α-synuclein

Mesh:

Substances:

Year:  2016        PMID: 26940375     DOI: 10.1111/bpa.12373

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  30 in total

Review 1.  How strong is the evidence that Parkinson's disease is a prion disorder?

Authors:  Patrik Brundin; Jiyan Ma; Jeffrey H Kordower
Journal:  Curr Opin Neurol       Date:  2016-08       Impact factor: 5.710

2.  Clearance of intracellular tau protein from neuronal cells via VAMP8-induced secretion.

Authors:  Julie Pilliod; Alexandre Desjardins; Camille Pernègre; Hélène Jamann; Catherine Larochelle; Edward A Fon; Nicole Leclerc
Journal:  J Biol Chem       Date:  2020-10-22       Impact factor: 5.157

Review 3.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-18       Impact factor: 3.575

4.  Secondary Release of Exosomes From Astrocytes Contributes to the Increase in Neural Plasticity and Improvement of Functional Recovery After Stroke in Rats Treated With Exosomes Harvested From MicroRNA 133b-Overexpressing Multipotent Mesenchymal Stromal Cells.

Authors:  Hongqi Xin; Fengjie Wang; Yanfeng Li; Qing-E Lu; Wing Lee Cheung; Yi Zhang; Zheng Gang Zhang; Michael Chopp
Journal:  Cell Transplant       Date:  2016-09-26       Impact factor: 4.064

Review 5.  Proteostatic imbalance and protein spreading in amyotrophic lateral sclerosis.

Authors:  Maria Elena Cicardi; Lara Marrone; Mimoun Azzouz; Davide Trotti
Journal:  EMBO J       Date:  2021-03-31       Impact factor: 11.598

6.  Clearance of intracellular tau protein from neuronal cells via VAMP8-induced secretion.

Authors:  Julie Pilliod; Alexandre Desjardins; Camille Pernègre; Hélène Jamann; Catherine Larochelle; Edward A Fon; Nicole Leclerc
Journal:  J Biol Chem       Date:  2020-12-18       Impact factor: 5.157

7.  Decreased glucocerebrosidase activity and substrate accumulation of glycosphingolipids in a novel GBA1 D409V knock-in mouse model.

Authors:  Nicole K Polinski; Terina N Martinez; Alexander Gorodinsky; Ralph Gareus; Michael Sasner; Mark Herberth; Robert Switzer; Syed O Ahmad; Mali Cosden; Monika Kandebo; Robert E Drolet; Peter D Buckett; Weisong Shan; Yi Chen; Lee J Pellegrino; Gregory D Ellsworth; Leo B Dungan; Warren D Hirst; Sean W Clark; Kuldip D Dave
Journal:  PLoS One       Date:  2021-06-09       Impact factor: 3.240

Review 8.  Innovative treatment targeting gangliosides aimed at blocking the formation of neurotoxic α-synuclein oligomers in Parkinson's disease.

Authors:  Nouara Yahi; Coralie Di Scala; Henri Chahinian; Jacques Fantini
Journal:  Glycoconj J       Date:  2021-07-30       Impact factor: 2.916

Review 9.  Alpha-synuclein research: defining strategic moves in the battle against Parkinson's disease.

Authors:  Luis M A Oliveira; Thomas Gasser; Robert Edwards; Markus Zweckstetter; Ronald Melki; Leonidas Stefanis; Hilal A Lashuel; David Sulzer; Kostas Vekrellis; Glenda M Halliday; Julianna J Tomlinson; Michael Schlossmacher; Poul Henning Jensen; Julia Schulze-Hentrich; Olaf Riess; Warren D Hirst; Omar El-Agnaf; Brit Mollenhauer; Peter Lansbury; Tiago F Outeiro
Journal:  NPJ Parkinsons Dis       Date:  2021-07-26

Review 10.  Vacuolar Protein Sorting Genes in Parkinson's Disease: A Re-appraisal of Mutations Detection Rate and Neurobiology of Disease.

Authors:  Stefano Gambardella; Francesca Biagioni; Rosangela Ferese; Carla L Busceti; Alessandro Frati; Giuseppe Novelli; Stefano Ruggieri; Francesco Fornai
Journal:  Front Neurosci       Date:  2016-11-24       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.